REPLIGEN CORP — Director's Dealing 2021

Mar 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2021-03-12

Reporting Person: RYAN THOMAS F JR (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-12	Common Stock	G	170	$0.00	Disposed	1294	Direct

Footnotes

F1: The shares were disposed of in connection with a bona fide gift by the Reporting Person to a donor advised fund.